Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

SQI Diagnostics Inc V.SQD.H

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.


TSXV:SQD.H - Post by User

Comment by FactFinder1994on Apr 07, 2021 11:18pm
122 Views
Post# 32954906

RE:NASDAQ

RE:NASDAQThere has been no lack of vision here for many many years, and a couple decades of dedication by the founder (Dr. Peter Lea).  The science, quality and innovation here is truly exceptional.  Having followed the product evolution for much of the last decade, it is now ready for exploitation.  Credit to the entire science team and to the prior CEO (Andrew Morris) for bringing the company to this pivotal moment.  Executing the UHN partnership especially, is brilliant for all.        
Making room for an American CEO (Rob Chioini) with prior success seems prudent for the remaining late stage activities as transition to Nasdaq takes place as well.
Rob has been extremely quiet over the last eight months, but it seems others here are suggesting his presence will soon be felt.  I haven't come across the word "imminent" regarding Nasdaq listing yet, but perhaps thats about to change...?

Its a great story, now lets make it known!  
  

<< Previous
Bullboard Posts
Next >>